1. Song, Ying, Zhang, Weilong, He, Xue, Jing, Hongmei, Yuan, Xiaoliang. 2019. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. In Journal of translational medicine, 17, 166. doi:10.1186/s12967-019-1904-5. https://pubmed.ncbi.nlm.nih.gov/31109331/
2. Luo, Dan, Liang, Yiran, Wang, Yajie, Jiang, Liyu, Yang, Qifeng. 2023. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD. In Breast cancer research : BCR, 25, 109. doi:10.1186/s13058-023-01709-1. https://pubmed.ncbi.nlm.nih.gov/37770991/
3. Dong, Caihua, Yin, Fuqiang, Zhu, Dan, Chen, Cuilan, Liu, Xia. 2020. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer. In Journal of cellular biochemistry, 121, 4470-4483. doi:10.1002/jcb.29670. https://pubmed.ncbi.nlm.nih.gov/32030795/
4. Torres-Benito, Laura, Schneider, Svenja, Rombo, Roman, Bennett, C Frank, Wirth, Brunhilde. 2019. NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice. In American journal of human genetics, 105, 221-230. doi:10.1016/j.ajhg.2019.05.008. https://pubmed.ncbi.nlm.nih.gov/31230718/
5. Wang, W, Zhou, Z, Zhao, W, Xie, Y, Mao, Y. . Molecular cloning, mapping and characterization of the human neurocalcin delta gene (NCALD). In Biochimica et biophysica acta, 1518, 162-7. doi:. https://pubmed.ncbi.nlm.nih.gov/11267673/
6. Feng, Li-Yuan, Yan, Bing-Bing, Huang, Yong-Zhi, Li, Li. 2021. Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer. In Clinical epigenetics, 13, 141. doi:10.1186/s13148-021-01133-2. https://pubmed.ncbi.nlm.nih.gov/34289901/
智鼠故事 
